IL-22 plays a protective role in the liver, promoting hepatocyte survival and proliferation through the activation of signaling pathways (e.g., the STAT3 pathway) in hepatocytes, thereby reducing hepatocyte injury caused by NAFLD. Here, IL22 is linked to metabolic dysfunction-associated steatotic liver disease.